Investing
225 Articles
US equity markets opened lower this morning, but after the first hour or so of trading, the three major indexes…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…
Today is Facebook Day. It will be remembered that way as long as there are IPOs. The Facebook public offering has…
Drug maker AstraZeneca PLC (NYSE: AZN) has issued a press release re-confirming the company’s December forecast following a load of…
Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that…
Pharmaceutical company AstraZeneca plc (NYSE: AZN) is looking for another big winner to replace its Nexium heartburn drug and its…
Layoffs were part of the business news yesterday. Enough people lost jobs in a series of three “downsizings” to reminds…
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1…
Equities started the day with a solid move up, but lost momentum after about half an hour. The downward move…
These are some of Tuesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Aixtron SE (NASDAQ:…
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability.…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday…
We may have just witnessed an oversold bounce in the stock market, or we may be in for more days…
Our top personal finance-related articles today. Your wallet will thank you later.